Travere Therapeutics (TVTX) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Travere Therapeutics (TVTX) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 21.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.81% |
| Dec 31, 2025 | 22.35% |
| Sep 30, 2025 | 32.14% |
| Jun 30, 2025 | 71.92% |
| Mar 31, 2025 | 20.05% |
| Dec 31, 2024 | -187.40% |
| Sep 30, 2024 | -2.94% |
| Jun 30, 2024 | -45.84% |
| Mar 31, 2024 | -67.09% |
| Dec 31, 2023 | -54.96% |
| Sep 30, 2023 | -42.82% |
| Jun 30, 2023 | -90.76% |
| Mar 31, 2023 | -56.65% |
| Dec 31, 2022 | -90.92% |
| Sep 30, 2022 | -13.90% |
| Jun 30, 2022 | -7.32% |
| Mar 31, 2022 | -45.67% |
| Dec 31, 2021 | -20.60% |
| Sep 30, 2021 | 22.50% |
| Dec 31, 2020 | 97.44% |